Tessier Jon E, Rupp Gerald, Gera Jim T, DeHart Matthew L, Kowalik Tom D, Duwelius Paul J
Signature Medical Group, St Louis, Missouri.
Orthopedic Institute, Providence Health & Services, Portland, Oregon.
J Arthroplasty. 2016 Sep;31(9 Suppl):54-8. doi: 10.1016/j.arth.2016.05.001. Epub 2016 May 11.
There is a pronounced need for a sustainable care model for total joint arthroplasty in the United States. Total hip and knee arthroplasty is expected to increase 673% by 2030, and Medicare is the payor for a majority of these episodes. Our objective was to compare orthopedic cohort groups with and without defined postacute care pathways and the effects of the care pathways on service utilization and cost for Medicare patients in the Bundled Payments for Care Improvement program.
Claims data for elective hip and knee arthroplasty episodes from a national bundled payments for care improvement database were the source of our study data. Independent reviewers were used to determine which groups had defined clinical pathways. The 2 cohort groups were then compared between those with defined clinical pathways and those without. Outcomes measures included postacute care costs, utilization rates (both frequency and length of time) for inpatient rehabilitation facilities, skilled nursing facilities, home health, and readmissions.
Orthopedic physicians with defined postacute care pathways showed consistent decreases in cost and utilization as compared to physicians without defined postacute care pathways. Elective hip arthroplasty per episode cost differential was $3189 per episode between physicians with care pathways ($19,005) and those without ($22,195; P < .001). Elective knee arthroplasty per episode cost difference was $2466 per episode between physicians with care pathways ($18,866) and those without ($21,332; P < .001). Incident rates of utilization for postacute care services displayed significant differences between physicians with and without postacute care pathways. Physicians with defined postacute pathways demonstrated utilization reductions ranging from 7% to 79% with incident rate reductions ranging from 44% to 79%.
The results suggest that orthopedic physicians with defined postacute care pathways affect discharge disposition. The findings show significant cost and utilization reductions for physicians with defined postacute care pathways.
美国对全关节置换术的可持续护理模式有着迫切需求。预计到2030年,全髋关节和膝关节置换术将增长673%,而医疗保险是这些病例中大多数的支付方。我们的目标是比较有和没有明确急性后护理路径的骨科队列组,以及护理路径对改善护理捆绑支付计划中医疗保险患者服务利用和成本的影响。
我们的研究数据来源于一个全国性的改善护理捆绑支付数据库中择期髋关节和膝关节置换术病例的索赔数据。由独立评审员确定哪些组有明确的临床路径。然后对有明确临床路径和没有明确临床路径的两组队列进行比较。结果指标包括急性后护理成本、住院康复设施、专业护理设施、家庭健康护理的利用率(频率和时长)以及再入院情况。
与没有明确急性后护理路径的骨科医生相比,有明确急性后护理路径的骨科医生在成本和利用率方面持续下降。有护理路径的医生(19,005美元)和没有护理路径的医生(22,195美元)之间,择期髋关节置换术每例成本差异为3189美元(P <.001)。有护理路径的医生(18,866美元)和没有护理路径的医生(21,332美元)之间,择期膝关节置换术每例成本差异为2466美元(P <.001)。急性后护理服务的利用率在有和没有急性后护理路径的医生之间存在显著差异。有明确急性后护理路径的医生利用率降低了7%至79%,发生率降低了44%至79%。
结果表明,有明确急性后护理路径的骨科医生会影响出院处置。研究结果显示,有明确急性后护理路径的医生在成本和利用率方面有显著降低。